The Use of Prostaglandins in the Immediate Postsurgical Liver Transplant Period

Transplantation Proceedings

Volumn 38, Issue 4, 2006, Pages 1092-1095

  Gatta, A ^a   Dante, A ^a   Del Gaudio, M ^a   Pinna, A D ^a   Ravaioli, M ^a   Riganello, I ^a   Volta, G ^a   Faenza, S ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; NITROGEN; PROSTAGLANDIN E1; THROMBOPLASTIN; UREA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIURESIS; DRUG EFFICACY; FEMALE; GRAFT DYSFUNCTION; HEPATOBILIARY SYSTEM; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER CLEARANCE; LIVER DYSFUNCTION; LIVER PERFUSION; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE CARE; PRIORITY JOURNAL; THROMBOPLASTIN TIME; UREA NITROGEN BLOOD LEVEL; VASODILATATION;

ALPROSTADIL; BILIRUBIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INTERNATIONAL NORMALIZED RATIO; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; OXYGEN; POSTOPERATIVE PERIOD; TIME FACTORS; UREA;

EID: 33744543034     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.03.046     Document Type: Article

References (29)

1. Colletti L.M., Burtch G.D., and Campbell Jr. D.A. Prostaglandin E2 protects the isolated perfused rabbit liver from an oxygen free radical-induced injury. Transplant Proc 22 (1990) 2381
2. Lou J., Buhler L., Deng S., et al. Inhibition of leukocyte adherence and transendothelial migration in cultured human liver vascular endothelial cells by prostaglandin E1. Hepatology 27 (1998) 822
3. Merion R.M. Prostaglandin in liver transplantation. Adv Exp Med Biol 433 (1997) 13
4. Quiroga J., and Prieto J. Liver cytoprotection by prostaglandins. Pharmacol Ther 58 (1993) 67
5. Itasaka H., Suehiro T., Wakiyama S., et al. The mechanism of hepatic graft protection against reperfusion injury by prostaglandin E1. Surg Today 29 (1999) 526
6. Yang H., Majno P., Morel P., et al. Prostaglandin E1 human liver sinusoidal endothelial cell from apoptosis induced by hypoxia reoxygenation. Microvasc Res 64 (2002) 94
7. Himmelreich G., Hundt K., Neuhaus P., et al. Evidence that intraoperative prostaglandin E1 infusion reduce impaired platelet aggregation after reperfusion in orthotopic liver transplantation. Transplantation 55 (1993) 819
8. Ciwes R., Harvey P.R.C., Packham M.A., et al. The influence of prostaglandin E1 on platelet adherence and injury in preserved rat liver allografts. Liver Transpl Surg 2 (1996) 23
9. Tsukada K., Sakaguchi T., Tomiyama T., et al. Enhanced hepatic portal blood flow induced by prostaglandin E1 following liver transplantation in pigs. Surg Today 24 (1994) 621
10. Oishi M., Tanaka N., and Orita K. Beneficial effects of prostaglandin E1 on hemodynamic changes during liver transplantation in pigs. Transpl Int 9 suppl (1996) S100
11. Chavin K.D., Uber L., Baliga P., et al. The effect of prostaglandin E1 on hepatic allograft vascular inflow. a prospective randomised double-blind study. Am Surg 62 (1996) 184
12. Kornberg A., Grube T., Wagner T., et al. Differentiated therapy with prostaglandin E1 (alprostadil) after orthotopic liver transplantation. the usefulness of procalcitonin (PCT) and hepatic artery resistive index (RI) for the evaluation of early graft function and clinical course. Clin Chem Lab Med 38 (2000) 1177
13. Kornberg A., Schotte U., Kupper B., et al. Impact of selective prostaglandin E1 treatment on graft perfusion and function after liver transplantation. Hepatogastroenterology 51 (2004) 526
14. Morioka D., Kubota T., Sekido H., et al. Prostaglandin E1 improved the function of transplanted fatty liver in a rat reduced-size-liver transplantation model under conditions of permissible cold preservation. Liver Transpl 9 (2003) 79
15. Kawachi S., Shimazu M., Wakabayashi G., et al. Efficacy of intraportal infusion of prostaglandin E1 to improve the hepatic blood flow and graft viability in porcine liver transplantation. Transplantation 64 (1997) 205
16. Hossain M.A., Hamamoto I., Wakabayashi H., et al. Experimental study of the effect of intraportal prostaglandin E1 on hepatic blood flow during reperfusion after ischaemia and hepatectomy. Br J Surg 86 (1999) 776
17. Tanabe M., Shimazu M., Wakabayashi G., et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 73 (2002) 1959
18. Inagaki H., Kurokawa T., Nonami T., et al. The effect of intraportal administration of prostaglandin E1 on liver blood flow and liver function. Hepatogastroenterology 46 (1999) 2909
19. Greig P.D., Woolf G.M., Sinclair S.B., et al. Treatment of primary liver graft nonfunction with prostaglandin E1. Transplantation 48 (1989) 447
20. Alevizacos P., Bechestein W.O., Rossaint R., et al. Failure of PGE1 to prevent liver allograft reperfusion injury in a prospective randomised trial. Transplant Proc 25 (1993) 2545
21. Grazi G.L., Mazziotti A., Jovine E., et al. Prostaglandin therapy in primary liver graft nonfunction after orthotopic transplantation. Transplant Proc 26 (1994) 3651
22. Takaya S., Doyle H., Todo S., et al. Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation. Transplant Proc 27 (1995) 1862
23. Henley K.S., Lucey M.R., Normolle D.P., et al. A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation. Hepatology 21 (1995) 366
24. Klein A.S., Cofer J.B., Pruett T.L., et al. Prostaglandin E1 administration following orthotopic liver transplantation. a randomized prospective multicenter trial. Gastroenterology 111 (1996) 710
25. Smith D.G., Henley K.S., Remmert C.S., et al. A cost analysis of alprostadil in liver transplantation. Pharmacoeconomics 9 (1996) 517
26. Ismail T., Ayres R., Kiff P., et al. Enisoprost in liver transplantation. Transplantation 59 (1995) 1298
27. Manasia A.R., Leibowitz A.B., Miller C.M., et al. Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients. J Am Coll Surg 182 (1995) 347
28. Ray J.G. Prostaglandin E1 analogs do not improve renal function among either transplant or nontransplant patients. No further trials required. Transplantation 66 (1998) 476
29. Candela-Toha A.M., Martiinez-Perez A., and Liaño F. Prostaglandin E1 analogs do not improve renal function among either transplant or nontrasplant patients. No further trials required?. Transplantation 68 (1999) 166 letter